BOFAS Abstracts Archive

You can search for abstracts by using the search bar below.
Alternatively you can browse through podium and poster presentations by selecting the year and / or type below. You can further refine your search using tags or use the search bar.

Search

RSS Abstracts 476 Expand/Collapse
- RSS 2013 64 Expand/Collapse
  - RSS Poster 24 Expand/Collapse
  - RSS Podium 40 Expand/Collapse
- RSS 2014 36 Expand/Collapse
  - RSS Podium 36 Expand/Collapse
- RSS 2015 49 Expand/Collapse
  - RSS Poster 20 Expand/Collapse
  - RSS Podium 29 Expand/Collapse
- RSS 2016 45 Expand/Collapse
  - RSS Poster 18 Expand/Collapse
  - RSS Podium 27 Expand/Collapse
- RSS 2017 40 Expand/Collapse
  - RSS Poster 15 Expand/Collapse
  - RSS Podium 25 Expand/Collapse
- RSS 2018 47 Expand/Collapse
  - RSS Poster 22 Expand/Collapse
  - RSS Podium 25 Expand/Collapse
- RSS 2019 48 Expand/Collapse
  - RSS Poster 25 Expand/Collapse
  - RSS Podium 23 Expand/Collapse
- RSS 2021 15 Expand/Collapse
  - RSS Poster 10 Expand/Collapse
  - RSS Podium 6 Expand/Collapse
- RSS 2022 46 Expand/Collapse
  - RSS Poster 23 Expand/Collapse
  - RSS Podium 23 Expand/Collapse
- RSS 2023 46 Expand/Collapse
  - RSS Poster 23 Expand/Collapse
  - RSS Podium 23 Expand/Collapse
- RSS 2024 40 Expand/Collapse
  - RSS Poster 18 Expand/Collapse
  - RSS Podium 22 Expand/Collapse

Categories: Abstracts, 2021, Poster

Tumors of the foot and ankle: analysis of a 10 years’ experience from a large UK tumor center

R. Colta, V. Sethurajah, C. Loizou, M. Rogers, B. Sharp, R. Brown

¹Nuffield Orthopaedic Center, Oxford, United Kingdom

Introduction: Among the musculoskeletal system, tumors localized to the foot and ankle are not common. Most tumors of the foot and ankle will be benign, and it has been easy for clinicians to underestimate the malignant potential of a given tumor. The purpose of our study was to describe the largest UK experience with different tumor types of the foot and ankle, who underwent surgical excision, from a single tumor center over a 10 years' period.

Methods: A retrospective review was performed using the clinical records of all patients with histologically confirmed musculoskeletal tumors of the foot and ankle, treated between 2010 and 2019 at our institution. The data was analyzed regarding epidemiologic information, entity and localization. Included were all cases with a true tumor of the foot and ankle. Exclusion criteria were incomplete information on the patient’s histopathological diagnosis, infection and inflammatory conditions.

Results: Our series included 496 patients of which 31.6% were men, with an overall mean age at diagnosis of 46.7 years. Overall 457 lesions (92.1%) were nonmalignant and 39 (7.9%) were malignant. Soft tissue lesions were diagnosed in 456 cases (91.9%), out of which 422 (92.5 %) were benign. Bone lesions were diagnosed in 40 cases (8.1%) out of which 5 (12.5 %) were malignant. 25.6 % of the tumors were localized at the ankle and 74.4% at the foot level.

Conclusion: Foot and ankle tumors are rare compared with many other lesions, and physicians approaching a patient with foot and ankle lesions should always include malignant neoplastic disease in the differential diagnosis. Knowledge of incidence and distribution patterns of foot and ankle tumors will help to correctly assess unclear masses and initiate the right steps in further diagnostics and treatment. Unawareness can lead to delayed diagnosis and inadequate treatment with serious consequences for patients.

Print

Tags: Tumour

Documents to download

P10 Tumours(.pdf, 392.18 KB) - 787 download(s)

Click thumbnail below to view poster / thumbnail:

Archive of Abstracts